Actemra RoActemra Tocilizumab Roche
35,000 - 40,000 Per Bottle
10 Bottle (MOQ)
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor.